Alveolar epithelial cell-derived prostaglandin E2 serves as a request signal for macrophage secretion of suppressor of cytokine signaling 3 during innate inflammation

Journal of Immunology

Volumn 196, Issue 12, 2016, Pages 5112-5120

  Speth, Jennifer M ^a   Bourdonnay, Emilie ^a,c   Penke, Loka Raghu Kumar ^a   Mancuso, Peter ^a,b   Moore, Bethany B ^a   Weinberg, Jason B ^a   Peters Golden, Marc ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2; SUPPRESSOR OF CYTOKINE SIGNALING 3; CULTURE MEDIUM; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E SYNTHASE; SOCS3 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE DELETION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DEFICIENCY; GENETICS; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; SECRETION (PROCESS); TUMOR CELL LINE; VIROLOGY;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA; DINOPROSTONE; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; PROSTAGLANDIN-E SYNTHASES; RATS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN;

EID: 84974817839     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502153     Document Type: Article

References (65)

1. Hussell, T., and T. J. Bell. 2014. Alveolar macrophages: plasticity in a tissuespecific context. Nat. Rev. Immunol. 14: 81-93.
2. Hyde, D. M., N. K. Tyler, L. F. Putney, P. Singh, and H. J. Gundersen. 2004. Total number and mean size of alveoli in mammalian lung estimated using fractionator sampling and unbiased estimates of the Euler characteristic of alveolar openings. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 277: 216-226.
3. Westphalen, K., G. A. Gusarova, M. N. Islam, M. Subramanian, T. S. Cohen, A. S. Prince, and J. Bhattacharya. 2014. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506: 503-506.
4. Chuquimia, O. D., D. H. Petursdottir, N. Periolo, and C. Fernández. 2013. Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect. Immun. 81: 381-389.
5. Chuquimia, O. D., D. H. Petursdottir, M. J. Rahman, K. Hartl, M. Singh, and C. Fernández. 2012. The role of alveolar epithelial cells in initiating and shaping pulmonary immune responses: communication between innate and adaptive immune systems. PLoS One 7: e32125.
6. Féréol, S., R. Fodil, G. Pelle, B. Louis, and D. Isabey. 2008. Cell mechanics of alveolar epithelial cells (AECs) and macrophages (AMs). Respir. Physiol. Neurobiol. 163: 3-16.
7. Williams, M. C. 2003. Alveolar type I cells: molecular phenotype and development. Annu. Rev. Physiol. 65: 669-695.
8. Castranova, V., J. Rabovsky, J. H. Tucker, and P. R. Miles. 1988. The alveolar type II epithelial cell: A multifunctional pneumocyte. Toxicol. Appl. Pharmacol. 93: 472-483.
9. Fehrenbach, H. 2001. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir. Res. 2: 33-46.
10. Holt, P. G., D. H. Strickland, M. E. Wikström, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8: 142-152.
11. Quinton, L. J., M. R. Jones, B. E. Robson, B. T. Simms, J. A. Whitsett, and J. P. Mizgerd. 2008. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 38: 699-706.
12. Wang, S., G. Zheng, L. Zhao, F. Xu, and J. Qian. 2015. Shp-2 contributes to anti-RSVactivity in human pulmonary alveolar epithelial cells by interfering with the IFN-A-induced Jak/Stat1 pathway. J. Cell. Mol. Med. 19: 2432-2440.
13. Bourdonnay, E., Z. Zasłona, L. R. Penke, J. M. Speth, D. J. Schneider, S. Przybranowski, J. A. Swanson, P. Mancuso, C. M. Freeman, J. L. Curtis, and M. Peters-Golden. 2015. Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling. J. Exp. Med. 212: 729-742.
14. Akram, K. M., N. J. Lomas, N. R. Forsyth, and M. A. Spiteri. 2014. Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of proapoptotic marker p53. Int. J. Clin. Exp. Pathol. 7: 552-564.
15. Trebino, C. E., J. L. Stock, C. P. Gibbons, B. M. Naiman, T. S. Wachtmann, J. P. Umland, K. Pandher, J. M. Lapointe, S. Saha, M. L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 100: 9044-9049.
16. Barth, K., J. Reh, A. Sturrock, and M. Kasper. 2005. Epithelial vs myofibroblast differentiation in immortal rat lung cell lines-modulating effects of bleomycin. Histochem. Cell Biol. 124: 453-464.
17. Miller, Y. E., S. R. Walker, J. S. Spencer, R. T. Kubo, and R. J. Mason. 1989. Monoclonal antibodies specific for antigens expressed by rat type II alveolar epithelial and nonciliated bronchiolar cells. Exp. Lung Res. 15: 635-649.
18. Aronoff, D. M., C. Canetti, and M. Peters-Golden. 2004. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptormediated increase in intracellular cyclic AMP. J. Immunol. 173: 559-565.
19. Turiák, L., P. Misják, T. G. Szabó , B. Aradi, K. Páló czi, O. Ozohanics, L. Drahos, A. Kittel, A. Falus, E. I. Buzás, and K. Vékey. 2011. Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice. J. Proteomics 74: 2025-2033.
20. Moore, B. B., M. J. Coffey, P. Christensen, S. Sitterding, R. Ngan, C. A. Wilke, R. McDonald, S. M. Phare, M. Peters-Golden, R. Paine, III, and G. B. Toews. 2000. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J. Immunol. 165: 4032-4039.
21. McCarthy, M. K., R. E. Levine, M. C. Procario, P. J. McDonnell, L. Zhu, P. Mancuso, L. J. Crofford, D. M. Aronoff, and J. B. Weinberg. 2013. Prostaglandin E2 induction during mouse adenovirus type 1 respiratory infection regulates inflammatory mediator generation but does not affect viral pathogenesis. PLoS One 8: e77628.
22. McMillan, T. R., B. B. Moore, J. B. Weinberg, K. M. Vannella, W. B. Fields, P. J. Christensen, L. F. van Dyk, and G. B. Toews. 2008. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am. J. Respir. Crit. Care Med. 177: 771-780.
23. Carow, B., and M. E. Rottenberg. 2014. SOCS3, a Major Regulator of Infection and Inflammation. Front. Immunol. 5: 58.
24. Dalpke, A. H., S. Opper, S. Zimmermann, and K. Heeg. 2001. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166: 7082-7089.
25. Severgnini, M., S. Takahashi, L. M. Rozo, R. J. Homer, C. Kuhn, J. W. Jhung, G. Perides, M. Steer, P. M. Hassoun, B. L. Fanburg, et al. 2004. Activation of the STAT pathway in acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1282-L1292.
26. Hilberath, J. N., T. Carlo, M. A. Pfeffer, R. H. Croze, F. Hastrup, and B. D. Levy. 2011. Resolution of Toll-like receptor 4-mediated acute lung injury is linked to eicosanoids and suppressor of cytokine signaling 3. FASEB J. 25: 1827-1835.
27. Yan, C., P. A. Ward, X. Wang, and H. Gao. 2013. Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein d pathway. FASEB J. 27: 2967-2976.
28. Harmsen, A. G. 1988. Role of alveolar macrophages in lipopolysaccharideinduced neutrophil accumulation. Infect. Immun. 56: 1858-1863.
29. Johnson, B. L., J. W. Iii, J. W. Kuethe, and C. C. Caldwell. 2014. Neutrophil derived microvesicles: emerging role of a key mediator to the immune response. Endocr. Metab. Immune Disord. Drug Targets 14: 210-217.
30. Cash, J. L., G. E. White, and D. R. Greaves. 2009. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol. 461: 379-396.
31. Chaves de Souza, J. A., A. V. Nogueira, P. P. Chaves de Souza, Y. J. Kim, C. Silva Lobo, G. J. Pimentel Lopes de Oliveira, J. A. Cirelli, G. P. Garlet, and C. Rossa, Jr. 2013. SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo. Mediators Inflamm. 2013: 650812.
32. Lama, V., B. B. Moore, P. Christensen, G. B. Toews, and M. Peters-Golden. 2002. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am. J. Respir. Cell Mol. Biol. 27: 752-758.
33. Petrovic, N., D. A. Knight, J. S. Bomalaski, P. J. Thompson, and N. L. Misso. 2006. Concomitant activation of extracellular signal-regulated kinase and induction of COX-2 stimulates maximum prostaglandin E2 synthesis in human airway epithelial cells. Prostaglandins Other Lipid Mediat. 81: 126-135.
34. Standiford, T. J., S. L. Kunkel, S. H. Phan, B. J. Rollins, and R. M. Strieter. 1991. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J. Biol. Chem. 266: 9912-9918.
35. Kwong, K. Y., A. Literat, N. L. Zhu, H. H. Huang, C. Li, C. A. Jones, and P. Minoo. 2004. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: A pro-inflammatory mediator independent pathway. Life Sci. 74: 2941-2957.
36. Pottratz, S. T., S. Reese, and J. L. Sheldon. 1998. Pneumocystis carinii induces interleukin 6 production by an alveolar epithelial cell line. Eur. J. Clin. Invest. 28: 424-429.
37. Christensen, P. J., L. R. Armstrong, J. J. Fak, G. H. Chen, R. A. McDonald, G. B. Toews, and R. Paine, III. 1995. Regulation of rat pulmonary dendritic cell immunostimulatory activity by alveolar epithelial cell-derived granulocyte macrophage colony-stimulating factor. Am. J. Respir. Cell Mol. Biol. 13: 426-433.
38. Mitchell, J. A., M. G. Belvisi, P. Akarasereenont, R. A. Robbins, O. J. Kwon, J. Croxtall, P. J. Barnes, and J. R. Vane. 1994. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol. 113: 1008-1014.
39. Font-Nieves, M., M. G. Sans-Fons, R. Gorina, E. Bonfill-Teixidor, A. Salas-Pérdomo, L. Márquez-Kisinousky, T. Santalucia, and A. M. Planas. 2012. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes. J. Biol. Chem. 287: 6454-6468.
40. McVey, M., A. Tabuchi, and W. M. Kuebler. 2012. Microparticles and acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L364-L381.
41. Sadallah, S., C. Eken, and J. A. Schifferli. 2011. Ectosomes as immunomodulators. Semin. Immunopathol. 33: 487-495.
42. Sadallah, S., C. Eken, and J. A. Schifferli. 2011. Ectosomes as modulators of inflammation and immunity. Clin. Exp. Immunol. 163: 26-32.
43. Budoni, M., A. Fierabracci, R. Luciano, S. Petrini, V. Di Ciommo, and M. Muraca. 2013. The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant. 22: 369-379.
44. Sadallah, S., C. Eken, and J. A. Schifferli. 2008. Erythrocyte-derived ectosomes have immunosuppressive properties. J. Leukoc. Biol. 84: 1316-1325.
45. Tang, K., J. Liu, Z. Yang, B. Zhang, H. Zhang, C. Huang, J. Ma, G. X. Shen, D. Ye, and B. Huang. 2010. Microparticles mediate enzyme transfer from platelets to mast cells: A new pathway for lipoxin A4 biosynthesis. Biochem. Biophys. Res. Commun. 400: 432-436.
46. Chauncey, J. B., M. Peters-Golden, and R. H. Simon. 1988. Arachidonic acid metabolism by rat alveolar epithelial cells. Lab. Invest. 58: 133-140.
47. Lipchik, R. J., J. B. Chauncey, R. Paine, R. H. Simon, and M. Peters-Golden. 1990. Arachidonate metabolism increases as rat alveolar type II cells differentiate in vitro. Am. J. Physiol. 259: L73-L80.
48. Degraaf, A. J., Z. Zasłona, E. Bourdonnay, and M. Peters-Golden. 2014. Prostaglandin E2 reduces Toll-like receptor 4 expression in alveolar macrophages by inhibition of translation. Am. J. Respir. Cell Mol. Biol. 51: 242-250.
49. Serezani, C. H., J. Chung, M. N. Ballinger, B. B. Moore, D. M. Aronoff, and M. Peters-Golden. 2007. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am. J. Respir. Cell Mol. Biol. 37: 562-570.
50. Aronoff, D. M., I. L. Bergin, C. Lewis, D. Goel, E. OBrien, M. Peters-Golden, and P. Mancuso. 2012. E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. Prostaglandins Other Lipid Mediat. 98: 23-30.
51. Huang, S., S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden. 2007. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L405-L413.
52. Zasłona, Z., K. Okunishi, E. Bourdonnay, R. Domingo-Gonzalez, B. B. Moore, N. W. Lukacs, D. M. Aronoff, and M. Peters-Golden. 2014. Prostaglandin E suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells. J. Allergy Clin. Immunol. 133: 379-387.
53. Zaslona, Z., C. H. Serezani, K. Okunishi, D. M. Aronoff, and M. Peters-Golden. 2012. Prostaglandin E2 restrains macrophage maturation via E prostanoid receptor 2/protein kinase A signaling. Blood 119: 2358-2367.
54. Dranoff, G., A. D. Crawford, M. Sadelain, B. Ream, A. Rashid, R. T. Bronson, G. R. Dickersin, C. J. Bachurski, E. L. Mark, J. A. Whitsett, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
55. Stanley, E., G. J. Lieschke, D. Grail, D. Metcalf, G. Hodgson, J. A. Gall, D. W. Maher, J. Cebon, V. Sinickas, and A. R. Dunn. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91: 5592-5596.
56. Bonfield, T. L., B. Raychaudhuri, A. Malur, S. Abraham, B. C. Trapnell, M. S. Kavuru, and M. J. Thomassen. 2003. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L1132-L1136.
57. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105: 497-504.
58. Zhu, J., X. Huang, and Y. Yang. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and-independent pathways. J. Virol. 81: 3170-3180.
59. Bussey, K. A., E. Reimer, H. Todt, B. Denker, A. Gallo, A. Konrad, M. Ottinger, H. Adler, M. Sturzl, W. Brune, andM.M. Brinkmann. 2014. The gammaherpesviruses Kaposis sarcoma-Associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response. J. Virol. 88: 9245-9259.
60. Rhee, S. H., and D. Hwang. 2000. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J. Biol. Chem. 275: 34035-34040.
61. Weinlich, R., K. R. Bortoluci, C. F. Chehab, C. H. Serezani, A. G. Ulbrich, M. Peters-Golden, M. Russo, and G. P. Amarante-Mendes. 2008. TLR4/MYD88-dependent, LPS-induced synthesis of PGE2 by macrophages or dendritic cells prevents anti-CD3-mediated CD95L upregulation in T cells. Cell Death Differ. 15: 1901-1909.
62. Yeo, S. J., J. G. Yoon, and A. K. Yi. 2003. Myeloid differentiation factor 88-dependent post-Transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: Tumor necrosis factor-Alpha receptor-Associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J. Biol. Chem. 278: 40590-40600.
63. Gasser, O., C. Hess, S. Miot, C. Deon, J. C. Sanchez, and J. A. Schifferli. 2003. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp. Cell Res. 285: 243-257.
64. Hess, C., S. Sadallah, A. Hefti, R. Landmann, and J. A. Schifferli. 1999. Ectosomes released by human neutrophils are specialized functional units. J. Immunol. 163: 4564-4573.
65. Gasser, O., and J. A. Schifferli. 2004. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104: 2543-2548.